Fixing Drug Pricing Means Paying For “Value”
The following is a guest post by Yevgeniy Feyman, a senior research assistant in the department of health policy and management at the Harvard T.H. Chan School
The following is a guest post by Yevgeniy Feyman, a senior research assistant in the department of health policy and management at the Harvard T.H. Chan School
The following originally appeared on The Upshot (copyright 2016, The New York Times Company). It also appeared on page A3 of the September 8, 2016 print edition.
Work posted here under copyright © of the authors • Details on the Site Policies page